Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00582699 · ClinicalTrials.gov registry record
Depression, Cytokines and Pancreatic Cancer
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 80
- Enrollment target
NCT00582699: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00582699 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00582699 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
The purpose of this study is to measure certain specific chemicals in your blood, produced by the body in response to a stress, such as having pancreatic cancer. These chemicals are called "cytokines" and the researchers doing this study want to look at the role they may play in developing depression.
Interventions
- BEHAVIORAL assessment interview and blood draw
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2005-11 |
| Est. Completion | 2014-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00582699
The ClinicalTrials.gov registry entry for NCT00582699 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which assessment interview and blood draw is the first listed.
NCT00582699 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00582699 about?
NCT00582699 is a clinical study titled "Depression, Cytokines and Pancreatic Cancer". The purpose of this study is to measure certain specific chemicals in your blood, produced by the body in response to a stress, such as having pancreatic cancer. These chemicals are called "cytokines" and the researchers doing this study want to look at the role they may play in developing depressio...
What is the current status of trial NCT00582699?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2005-11. Estimated completion is 2014-04.
What interventions are being tested in trial NCT00582699?
The interventions under investigation include: assessment interview and blood draw (BEHAVIORAL).
Who is sponsoring clinical trial NCT00582699?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.